Asylia Diagnostics SRL
Asylia Diagnostics reported total assets of 552,090 € at the end of the 2024 financial year (annual accounts filed with the NBB on 04 Jul 2025).
The score of Asylia Diagnostics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity -8 % Total assets -24 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Asylia Diagnostics's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | −183,907 € | ||||
| Equity | 109,193 € | ||||
| Cash | 22,889 € | ||||
| EBITDA | −127,204 € | ||||
| Total assets | 552,090 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 10 Aug 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
- Year ended 31 Dec 2020filed on 28 Jul 2021
Asylia Diagnostics's financial analysis
- Solvency19.8%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Asylia Diagnostics
Asylia Diagnostics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0732.783.629
- VAT number
- BE0732783629
- Peppol
- Registered · 0208:0732783629 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Aug 2019
- Registered office
- 3001 Leuven
- Latest accounts
- 2024 · filed on 04 Jul 2025
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Asylia Diagnostics (SRL) has been based in Leuven since 2019, active in: research and experimental development on biotechnology. For 2024, it reports a net loss of 183,907 € and equity of 109,193 €; its revenue is not published. Its solvency stands at 19.8%, below the median of its sector (60.4%).
Companies similar to Asylia Diagnostics
Companies in the same business, of comparable size and area, outside its group.
- NasaPharm Research and experimental development on natural sciences and engineering Blegny · balance sheet 606,267 €
- Temple OrthoBiologics Research and experimental development on natural sciences and engineering Liège · balance sheet 692,165 €
- IR 4 Research and experimental development on natural sciences and engineering Auderghem · balance sheet 865,084 €
- Dokter Fries Claerhout Research and experimental development on natural sciences and engineering Poperinge · balance sheet 906,181 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Huisarts Nadine Costers Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 502,719 €
- Hans DE Vilder - Clinical Research Consultancy Research and experimental development on natural sciences and engineering Genk · balance sheet 267,868 €
- Nyemb Research and experimental development on natural sciences and engineering Tournai · balance sheet €1.15m
Frequently asked questions about Asylia Diagnostics
What is the revenue of Asylia Diagnostics?
Asylia Diagnostics files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Asylia Diagnostics?
In Belgium, the VAT number is the company number prefixed with BE: BE0732783629 for Asylia Diagnostics, if the company is VAT-registered. Its company number (CBE) is 0732.783.629.
Where is the registered office of Asylia Diagnostics?
According to the CBE register, the registered office of Asylia Diagnostics is in 3001 Leuven.
What is the equity of Asylia Diagnostics?
At the close of the 2024 financial year, the equity of Asylia Diagnostics amounts to 109,193 €, a solvency of 19.8% of total assets.
Who manages Asylia Diagnostics?
The register lists 4 active mandates at Asylia Diagnostics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Asylia Diagnostics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →